Alterations in gene expression in MEN1-associated insulinoma development.
OBJECTIVE
To identify gene expression alterations associated with insulinoma formation and progression in 2 mouse models of multiple endocrine neoplasia type 1.


METHODS
Mice were killed at 12 or 16 months, and pancreatic islets were isolated by enzymatic and physical disruption. Islets were separated by size representing control, normal, hyperplastic, and adenomous islets. RNA was isolated from these islets and profiled on Sentrix Mouse-6 Expression version 1 BeadChips. Array data were analyzed in GeneSpring.


RESULTS
One hundred and one genes that were significantly (P ≤ 0.05) altered in hyperplastic islets and insulinomas compared with normal islets were identified. Of these, 64 gene elements showed reduced messenger RNA levels and 37 gene elements had increased gene expression compared with control islets. Altered expression of 3 genes, namely, Gata6, Tspan8, and s100a8, was confirmed by quantitative reverse transcription-polymerase chain reaction, and aberrant levels of Tspan8 and Lmo2 protein measured by Western blot correlated with the changes in messenger RNA levels.


CONCLUSIONS
These results suggest that alterations in gene expression of Gata6, Tspan8, S100a8, and Lmo2 may act via novel pathways that play functionally important roles in Men1-associated tumor progression.
Serewko-Auret
Magdalena M
MM
Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia. Magdalena.Auret@qimr.edu.au
Mould
Arne W
AW
Loffler
Kelly A
KA
Duncan
Russell
R
Kay
Graham F
GF
Hayward
Nicholas K
NK
D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D000951:Antigens, Neoplasm / Q000235:genetics / Q000378:metabolism; D015153:Blotting, Western; D040501:Calgranulin A / Q000235:genetics / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D050993:GATA6 Transcription Factor / Q000235:genetics / Q000378:metabolism; D020869:Gene Expression Profiling; D006801:Humans; D007340:Insulinoma / Q000209:etiology / Q000235:genetics* / Q000378:metabolism; D007515:Islets of Langerhans / Q000378:metabolism / Q000473:pathology; D060588:LIM Domain Proteins; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D008667:Metalloproteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D057507:Mice, 129 Strain; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018761:Multiple Endocrine Neoplasia Type 1 / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D010190:Pancreatic Neoplasms / Q000209:etiology / Q000235:genetics* / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000172:deficiency / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D059470:Tetraspanins
D048868:Adaptor Proteins, Signal Transducing; D000951:Antigens, Neoplasm; D040501:Calgranulin A; D004268:DNA-Binding Proteins; D050993:GATA6 Transcription Factor; C494759:GATA6 protein, human; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; C105373:MEN1 protein, human; D008562:Membrane Glycoproteins; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins; C065609:TSPAN8 protein, human; D059470:Tetraspanins